These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8824847)

  • 21. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
    Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
    Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015.
    Keinan-Boker L; Friedman E; Silverman BG
    Cancer Epidemiol; 2018 Oct; 56():6-13. PubMed ID: 30015055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in reported incidence of primary malignant brain tumors in children in the United States.
    Smith MA; Freidlin B; Ries LA; Simon R
    J Natl Cancer Inst; 1998 Sep; 90(17):1269-77. PubMed ID: 9731733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system tumours among adolescents and young adults (15-39 years) in Southern and Eastern Europe: Registration improvements reveal higher incidence rates compared to the US.
    Georgakis MK; Panagopoulou P; Papathoma P; Tragiannidis A; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Sfakianos G; Nikas I; Kosmidis S; Razis E; Pourtsidis A; Kantzanou M; Dessypris N; Petridou ET
    Eur J Cancer; 2017 Nov; 86():46-58. PubMed ID: 28961466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.
    Hoffman S; Propp JM; McCarthy BJ
    Neuro Oncol; 2006 Jan; 8(1):27-37. PubMed ID: 16443945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
    Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
    Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and İzmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program.
    Eser S; Chang J; Charalambous H; Silverman B; Demetriou A; Yakut C; Nimri O; Pavlou P; Özgür S; Ziogas A; Stevens L; Ward K; Anton Culver H
    Turk J Gastroenterol; 2018 Jan; 29(1):36-44. PubMed ID: 29391306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
    Khanna V; Achey RL; Ostrom QT; Block-Beach H; Kruchko C; Barnholtz-Sloan JS; de Blank PM
    J Neurooncol; 2017 Dec; 135(3):433-441. PubMed ID: 28828582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreasing incidence rates of primary central nervous system lymphoma.
    Kadan-Lottick NS; Skluzacek MC; Gurney JG
    Cancer; 2002 Jul; 95(1):193-202. PubMed ID: 12115333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
    Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
    Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain cancer incidence: a comparison of active-duty military and general populations.
    Bytnar JA; Lin J; Eaglehouse YL; Enewold L; Shriver CD; Zhu K
    Eur J Cancer Prev; 2021 Jul; 30(4):328-333. PubMed ID: 32898014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Merkel cell carcinoma: changing incidence trends.
    Hodgson NC
    J Surg Oncol; 2005 Jan; 89(1):1-4. PubMed ID: 15611998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multistage carcinogenesis and the incidence of thyroid cancer in the US by sex, race, stage and histology.
    Meza R; Chang JT
    BMC Public Health; 2015 Aug; 15():789. PubMed ID: 26282269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
    Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013.
    Bright CJ; Rea DW; Francis A; Feltbower RG
    Cancer Epidemiol; 2016 Oct; 44():186-194. PubMed ID: 27632243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States.
    Saad AM; Abushouk AI; Al-Husseini MJ; Salahia S; Alrefai A; Afifi AM; Abdel-Daim MM
    Cardiovasc Pathol; 2018; 33():27-31. PubMed ID: 29414429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time trends in oligodendroglial and astrocytic tumor incidence.
    McCarthy BJ; Propp JM; Davis FG; Burger PC
    Neuroepidemiology; 2008; 30(1):34-44. PubMed ID: 18259099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.